[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622578":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":22,"centralContacts":34,"locations":42,"responsibleParty":96,"collaborators":98,"id":125,"slug":10,"hasResults":126,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":130,"eligibilityCriteria":131,"healthyVolunteers":132,"sex":133,"minAge":10,"maxAge":10,"enrollmentInfo":134,"targetDuration":137,"studyType":138,"phases":10,"briefSummary":139,"conditions":140,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":155},{"fullName":5,"class":6},"Fundació Institut Germans Trias i Pujol","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Myotonic Dystrophy Type 1 (DM1)",null,"The group included Individuals with a confirmed genetic diagnosis of Myotonic Dystrophy Type 1 (DM1)",[13],"Other: Patient Registry",{"label":15,"type":10,"description":16,"interventionNames":17},"Control","The group included control subjects as individuals without a genetic diagnosis of Myotonic Dystrophy Type 1 (DM1).",[13],[19],{"type":6,"name":20,"description":20,"armGroupLabels":21,"otherNames":10},"Patient Registry",[15,9],[23,27,31],{"name":24,"affiliation":25,"role":26},"Gisela Nogales Gadea, Ph.D.","Germans Trias i Pujol Research Institute","STUDY_DIRECTOR",{"name":28,"affiliation":29,"role":30},"Arturo Lopez Castel, Ph.D.","INCLIVA Instituto de Investigación Sanitaria","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":33,"role":30},"Virginia Arechavala-Gomeza, Ph.D.","IIS Biobizkaia",[35,39],{"name":24,"role":36,"phone":37,"phoneExt":10,"email":38},"CONTACT","(+34) 93 554 3050","gnogales@igtp.cat",{"name":40,"role":36,"phone":10,"phoneExt":10,"email":41},"Alvaro S Larran Mottino, Ph.D.","alarran@igtp.cat",[43,54,60,66,72,78,84,90],{"facility":44,"status":45,"city":46,"state":47,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":49},"Hospitals within the DM1 network","RECRUITING","Multiple Locations","Andalusia","Spain",[50,53],{"name":51,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Macarena Cabrera","dm1-hub@igtp.cat",{"name":51,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":55,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":56},"Basque Country",[57,59],{"name":58,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Andone Sistiaga",{"name":58,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":61,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":62},"Canary Islands",[63,65],{"name":64,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Jorge Alonso",{"name":64,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":67,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":68},"Cantabria",[69,71],{"name":70,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Ana Lara Pelayo",{"name":70,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":73,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":74},"Castilla-La Macha",[75,77],{"name":76,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Jorge García",{"name":76,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":79,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":80},"Catalonia",[81,83],{"name":82,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Sebastián Figueroa",{"name":82,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":85,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":86},"Madrid",[87,89],{"name":88,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Gerardo Gutiérrez",{"name":88,"role":30,"phone":10,"phoneExt":10,"email":10},{"facility":44,"status":45,"city":46,"state":91,"zip":10,"country":48,"cosmosGeoPoint":10,"geoPoint":10,"contacts":92},"Valencia",[93,95],{"name":94,"role":36,"phone":37,"phoneExt":10,"email":52},"Dr. Nuria Muelas",{"name":94,"role":30,"phone":10,"phoneExt":10,"email":10},{"type":97,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[99,101,104,106,108,110,112,114,116,118,120,122],{"name":100,"class":6},"Instituto de Investigacion Sanitaria INCLIVA",{"name":102,"class":103},"Biobizkaia Health Research Institute","OTHER_GOV",{"name":105,"class":6},"Biogipuzkoa Health Research Institute",{"name":107,"class":6},"Germans Trias i Pujol Hospital",{"name":109,"class":6},"Hospital Infanta Sofia",{"name":111,"class":6},"Hospital de Basurto",{"name":113,"class":6},"Hospital Donostia",{"name":115,"class":6},"Hospitales Universitarios Virgen del Rocío",{"name":117,"class":6},"Hospital Universitario Marqués de Valdecilla",{"name":119,"class":6},"Complejo Hospitalario Universitario de Albacete",{"name":121,"class":6},"Hospital Universitario La Fe",{"name":123,"class":124},"Hospital Univeritario Ntra. Sra. de la Candelaria","UNKNOWN","100622578",false,"NCT07385443","The Spanish National Registry for Myotonic Dystrophy Type 1","Creación de un Nodo Integral Para la Distrofia Miotónica Tipo 1 en España: Registro clínico, Mapas genómicos, epigenómicos y proteómicos (DM1-Hub)","DM1-Hub","Inclusion Criteria:\n\n* Confirmed diagnosis of Myotonic Dystrophy Type 1 (DM1) through genetic testing.\n\nExclusion Criteria:\n\n* There are no exclusion criteria for the registry",true,"ALL",{"count":135,"type":136},3000,"ESTIMATED","10 Years","OBSERVATIONAL","Myotonic Dystrophy Type 1 (DM1) is a rare genetic neuromuscular condition that can affect multiple organs and varies widely in how it presents. DM1 is the most common form of adult-onset muscular dystrophy, with an estimated prevalence of approximately 1-5 per 10,000 people. In Spain, the condition shows notable regional differences, making it especially important to understand its characteristics within the population.\n\nThe aim of this study is to support a research initiative designed to better characterise DM1. We are developing a comprehensive national registry, collecting patient-reported information, clinical data and omics data that will improve our understanding of the disease and help identify individuals who may be eligible for clinical trials.",[141,142,143,144,145],"Myotonic Dystrophy 1","DM1","Myotonic Dystrophy Type 1","Myotonic Dystrophy, Congenital","Steinert Disease","2026-01-29",{"date":148,"type":149},"2026-02-04","ACTUAL",{"date":151,"type":149},"2025-06-02",{"date":153,"type":136},"2026-12-31",{"name":5,"class":6},8]